14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $84.38 $110.93 Friday, 3rd May 2024 BPMC stock ended at $107.19. This is 0.178% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.50% from a day low at $106.15 to a day high of $110.93.
90 days $72.25 $110.93
52 weeks $43.89 $110.93

Historical Blueprint Medicines Corporation prices

Date Open High Low Close Volume
May 13, 2020 $63.46 $64.04 $61.91 $63.78 680 769
May 12, 2020 $65.79 $66.33 $63.24 $63.33 873 352
May 11, 2020 $60.25 $66.09 $60.00 $65.08 1 006 777
May 08, 2020 $61.22 $62.25 $59.04 $59.37 545 793
May 07, 2020 $60.04 $61.06 $58.32 $60.18 406 858
May 06, 2020 $58.29 $60.19 $57.48 $58.97 523 453
May 05, 2020 $59.75 $61.00 $58.61 $59.74 606 864
May 04, 2020 $56.98 $58.20 $56.00 $58.13 639 588
May 01, 2020 $58.00 $58.53 $56.51 $57.15 655 427
Apr 30, 2020 $60.00 $60.04 $58.37 $58.83 672 804
Apr 29, 2020 $59.10 $61.50 $58.18 $60.13 1 601 179
Apr 28, 2020 $61.00 $61.33 $56.12 $58.63 3 804 787
Apr 27, 2020 $71.93 $72.36 $70.36 $70.90 422 377
Apr 24, 2020 $70.10 $71.35 $68.78 $70.69 370 231
Apr 23, 2020 $70.68 $71.99 $68.76 $69.36 412 253
Apr 22, 2020 $71.30 $71.58 $69.51 $70.15 370 052
Apr 21, 2020 $70.46 $70.74 $68.22 $70.11 372 634
Apr 20, 2020 $68.89 $71.17 $68.76 $70.61 936 154
Apr 17, 2020 $69.66 $71.46 $68.40 $70.10 618 928
Apr 16, 2020 $65.00 $67.89 $63.81 $67.87 431 943
Apr 15, 2020 $65.00 $66.06 $64.00 $64.33 433 350
Apr 14, 2020 $64.85 $66.96 $64.67 $66.65 467 108
Apr 13, 2020 $66.12 $66.76 $63.64 $63.91 785 299
Apr 09, 2020 $67.75 $69.38 $63.76 $66.20 573 809
Apr 08, 2020 $65.94 $67.41 $64.44 $67.03 534 293
Click to get the best stock tips daily for free!

About Blueprint Medicines Corporation

Blueprint Medicines Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally avail... BPMC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT